checkAd

     137  0 Kommentare Endava Announces Third Quarter Fiscal Year 2024 Results

    Endava plc (NYSE: DAVA) ("Endava" or the "Company"), a leading technology services company combining world-class engineering, industry expertise and a people-centric mindset, today announced results for the three months ended March 31, 2024, the third quarter of its 2024 fiscal year ("Q3 FY2024").

    "Our revenue of £174.4 million for Q3 FY2024 was within our guidance, representing a decrease of 11.8% in constant currency year over year. The overall demand environment remains challenging but stable and we are seeing signs of increasing discretionary spending. Client behaviour is stabilising but sales cycles remain elongated,” said John Cotterell, Endava's CEO.

    THIRD QUARTER FISCAL YEAR 2024 FINANCIAL HIGHLIGHTS:

    • Revenue for Q3 FY2024 was £174.4 million, a decrease of 14.3% compared to £203.5 million in the same period in the prior year.
    • Revenue decrease at constant currency (a non-IFRS measure)* was 11.8% for Q3 FY2024, compared to growth of 14.6% in the same period in the prior year.
    • Loss before tax for Q3 FY2024 was £(0.5) million, compared to profit before tax of £30.4 million in the same period in the prior year.
    • Adjusted profit before tax (a non-IFRS measure)* for Q3 FY2024 was £15.5 million, or 8.9% of revenue, compared to £43.4 million, or 21.3% of revenue, in the same period in the prior year.
    • Loss for the period was £(1.7) million, resulting in a diluted earnings/(loss) per share ("EPS") of £(0.03), compared to profit of £24.4 million and diluted EPS of £0.42 in the same period in the prior year.
    • Adjusted profit for the period (a non-IFRS measure)* was £12.7 million, resulting in adjusted diluted EPS (a non-IFRS measure)* of £0.22, compared to adjusted profit for the period of £34.1 million and adjusted diluted EPS of £0.59 in the same period in the prior year.

    CASH FLOW:

    • Net cash from operating activities was £3.0 million in Q3 FY2024, compared to £25.1 million in the same period in the prior year.
    • Adjusted free cash flow (a non-IFRS measure)* was £2.2 million in Q3 FY2024, compared to £21.2 million in the same period in the prior year.
    • At March 31, 2024, Endava had cash and cash equivalents of £190.0 million, compared to £164.7 million at June 30, 2023. In April 2024, Endava used £129.0 million of cash for the acquisition of GalaxE.

    * Definitions of the non-IFRS measures used by the Company and a reconciliation of such measures to the related IFRS financial measure can be found under the sections below titled “Non-IFRS Financial Information” and “Reconciliation of IFRS Financial Measures to Non-IFRS Financial Measures.”

    OTHER METRICS FOR THE QUARTER ENDED MARCH 31, 2024:

    • Headcount totaled 11,025 at March 31, 2024, with an average of 10,127 operational employees in Q3 FY2024, compared to a headcount of 11,742 at March 31, 2023 and an average of 10,818 operational employees in the same period in the prior year.
    • Number of clients with over £1 million in revenue on a rolling twelve-month basis was 142 at March 31, 2024, compared to 155 clients at March 31, 2023.
    • Top 10 clients accounted for 34% of revenue in Q3 FY2024, compared to 33% in the same period in the prior year.
    • By geographic region, 30% of revenue was generated in North America, 28% was generated in Europe, 35% was generated in the United Kingdom and 7% was generated in the rest of the world in Q3 FY2024. This compares to 32% in North America, 24% in Europe, 38% in the United Kingdom and 6% in the Rest of the World in the same period in the prior year.
    • By industry vertical, 24% of revenue was generated from Payments, 14% from Banking and Capital Markets (BCM), 9% from Insurance, 24% from Technology, Media and Telecommunications (TMT), 10% from Mobility, and 19% from Other in Q3 FY2024. This compares to 29% from Payments, 16% from BCM, 8% from Insurance, 21% from TMT, 11% from Mobility, and 15% from Other in the same period in the prior year.

    OUTLOOK:

    Fourth Quarter Fiscal Year 2024:

    Endava expects revenue will be in the range of £195.0 million to £197.0 million, representing a constant currency revenue growth of between 3.5% and 4.5% on a year over year basis. Endava expects adjusted diluted EPS to be in the range of £0.22 to £0.23 per share.

    Full Fiscal Year 2024:

    Endava expects revenue will be in the range of £741.0 million to £743.0 million, representing a constant currency revenue decrease of between 4.5% and 4.0% on a year over year basis. Endava expects adjusted diluted EPS to be in the range of £1.13 to £1.14 per share.

    This above guidance for the fourth quarter and full fiscal year 2024 assumes the exchange rates on April 30, 2024 (when the exchange rate was 1 British Pound to 1.25 US Dollar and 1.17 Euro).

    Endava is not able, at this time, to reconcile its expectations for the fourth quarter and full fiscal year 2024 for a rate of revenue decrease at constant currency or adjusted diluted EPS to their respective most directly comparable IFRS measures as a result of the uncertainty regarding, and the potential variability of, reconciling items such as share-based compensation expense, amortisation of acquired intangible assets, foreign currency exchange (gains)/losses, restructuring costs and fair value movement of contingent consideration, as applicable. Accordingly, a reconciliation is not available without unreasonable effort, although it is important to note that these factors could be material to Endava's results computed in accordance with IFRS.

    The guidance provided above is forward-looking in nature. Actual results may differ materially. See “Forward-Looking Statements” below.

    CONFERENCE CALL DETAILS:

    The Company will host a conference call at 8:00 am ET today, May 23, 2024, to review its Q3 FY2024 results. To participate in Endava’s Q3 FY2024 earnings conference call, please dial in at least five minutes prior to the scheduled start time (844) 481-2736 or (412) 317-0665 for international participants, Conference ID: Endava Call.

    Investors may listen to the call on Endava’s Investor Relations website at http://investors.Endava.com. The webcast will be recorded and available for replay until Friday, June 28, 2024.

    ABOUT ENDAVA PLC:

    Technology is our how. And people are our why. By combining world-class engineering, industry expertise and a people-centric mindset, we consult and partner with our customers to create technological solutions that drive innovation and transform businesses. From ideation to production, we support our customers with tailor-made solutions across various industries and all around the world.

    Endava services clients in Payments, Banking and Capital Markets, Insurance, TMT, Consumer Products, Retail, Mobility and Healthcare. As of March 31, 2024, 11,025 Endavans provided services from our locations in European Union countries (Austria, Bulgaria, Croatia, Denmark, Germany, Ireland, the Netherlands, Poland, Romania, Slovenia and Sweden), non-European Union countries (Bosnia & Herzegovina, Moldova, North Macedonia, Serbia, Switzerland and the United Kingdom), Latin America (Argentina, Colombia, Mexico and Uruguay), Asia-Pacific (Australia, Malaysia, Singapore and Vietnam), North America (Canada and the United States), and the Middle East (United Arab Emirates).

    NON-IFRS FINANCIAL INFORMATION:

    To supplement Endava’s Condensed Consolidated Statements of Comprehensive Income, Condensed Consolidated Balance Sheets and Condensed Consolidated Statements of Cash Flows presented in accordance with IFRS, the Company uses non-IFRS measures of certain components of financial performance in this press release. These measures include revenue (decrease)/growth rate at constant currency, adjusted profit before tax, adjusted profit for the period, adjusted diluted EPS and adjusted free cash flow.

    Revenue (decrease)/growth rate at constant currency is calculated by translating revenue from entities reporting in foreign currencies into British Pounds using the comparable foreign currency exchange rates from the prior period. For example, the average currency rates in effect for the fiscal quarter ended March 31, 2023 were used to convert revenue for the fiscal quarter ended March 31, 2024 and the revenue for the comparable prior period.

    Adjusted profit before tax ("Adjusted PBT") is defined as the Company’s profit/(loss) before tax adjusted to exclude the impact of share-based compensation expense, amortisation of acquired intangible assets, realised and unrealised foreign currency exchange (gains)/losses, restructuring costs and fair value movement of contingent consideration, all of which are non-cash items except for the restructuring costs and realised foreign currency exchange (gains)/ losses.

    Adjusted profit for the period is defined as Adjusted PBT less the tax charge for the period adjusted for the tax impact of the adjustments to PBT.

    Adjusted diluted EPS is defined as Adjusted profit for the period, divided by weighted average number of shares outstanding - diluted.

    Adjusted free cash flow is the Company’s net cash from operating activities, plus grants received, less net purchases of non-current assets (tangible and intangible).

    Management believes these measures help illustrate underlying trends in the Company's business and uses the measures to establish budgets and operational goals, communicated internally and externally, for managing the Company's business and evaluating its performance. Management also believes the presentation of its non-IFRS financial measures enhances an investor’s overall understanding of the Company’s historical financial performance. The presentation of the Company’s non-IFRS financial measures is not meant to be considered in isolation or as a substitute for the Company’s financial results prepared in accordance with IFRS, and its non-IFRS measures may be different from non-IFRS measures used by other companies. Investors should review the reconciliation of the Company’s non-IFRS financial measures to the comparable IFRS financial measures included below, and not rely on any single financial measure to evaluate the Company’s business.

    FORWARD-LOOKING STATEMENTS:

    This press release includes forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements may be identified by the use of terms and phrases such as “believe,” “expect,” "outlook," “may,” “will,” and other similar terms and phrases. Such forward-looking statements include, but are not limited to, the statements regarding the overall demand environment and client behavior; and management's financial outlook for the fourth quarter and full fiscal year 2024. Forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially from the results anticipated by these forward-looking statements, including, but not limited to: Endava’s business, results of operations and financial condition may be negatively impacted by the Russia-Ukraine military conflict and related sanctions, conflict in the Middle East or if general economic conditions in Europe, the United States or the global economy worsen, including increased inflation and potential future bank failures; the perceived impact and effect of macroeconomic conditions on Endava and its customers; Endava’s ability to retain existing clients and attract new clients, including its ability to increase revenue from existing clients and diversify its revenue concentration; Endava’s ability to attract and retain highly-skilled IT professionals at cost-effective rates; Endava's ability to penetrate new industry verticals and geographies and grow its revenue in current industry verticals and geographies; Endava’s ability to maintain favorable pricing and utilization rates; Endava’s ability to successfully identify acquisition targets, consummate acquisitions and successfully integrate acquired businesses and personnel; the effects of increased competition as well as innovations by new and existing competitors in its market; Endava’s ability to adapt to technological change and innovate solutions for its clients; Endava’s ability to collect on billed and unbilled receivables from clients; Endava’s ability to effectively manage its international operations, including Endava's exposure to foreign currency exchange rate fluctuations; Endava’s ability to maintain an effective system of disclosure controls and internal control over financial reporting; and Endava’s future financial performance, including trends in revenue, cost of sales, gross profit, selling, general and administrative expenses, finance income and expense and taxes, as well as other risks and uncertainties discussed in the “Risk Factors” section of Endava's Annual Report on Form 20-F for the year ended June 30, 2023 filed with the SEC on September 19, 2023 and in other filings that Endava makes from time to time with the SEC. In addition, the forward-looking statements included in this press release represent Endava’s views and expectations as of the date hereof and are based on information currently available to Endava. Endava anticipates that subsequent events and developments may cause its views to change. Endava specifically disclaims any obligation to update the forward-looking statements in this press release except as required by law. These forward-looking statements should not be relied upon as representing Endava’s views as of any date subsequent to the date hereof.

    CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME

     

     

    Nine Months Ended
    March 31

    Three Months Ended
    March 31

     

    2024

    2023(1)

    2024

    2023(1)

     

    £’000

    £’000

    £’000

    £’000

    REVENUE

    546,338

     

    604,942

     

    174,365

     

    203,532

     

    Cost of sales

     

     

     

     

    Direct cost of sales

    (389,864

    )

    (381,711

    )

    (130,452

    )

    (132,458

    )

    Allocated cost of sales

    (19,938

    )

    (18,676

    )

    (6,720

    )

    (6,433

    )

    Total cost of sales

    (409,802

    )

    (400,387

    )

    (137,172

    )

    (138,891

    )

    GROSS PROFIT

    136,536

     

    204,555

     

    37,193

     

    64,641

     

    Selling, general and administrative expenses

    (117,643

    )

    (114,423

    )

    (39,025

    )

    (34,537

    )

    OPERATING PROFIT / (LOSS)

    18,893

     

    90,132

     

    (1,832

    )

    30,104

     

    Net finance income / (expense)

    8,496

     

    (905

    )

    1,303

     

    284

     

    PROFIT / (LOSS) BEFORE TAX

    27,389

     

    89,227

     

    (529

    )

    30,388

     

    Tax on profit on ordinary activities

    (8,413

    )

    (18,122

    )

    (1,208

    )

    (6,030

    )

    PROFIT / (LOSS) FOR THE PERIOD

    18,976

     

    71,105

     

    (1,737

    )

    24,358

     

    OTHER COMPREHENSIVE INCOME

     

     

     

     

    Items that may be reclassified subsequently to profit or loss:

     

     

     

     

    Exchange differences on translating foreign operations

    (1,061

    )

    (3,001

    )

    (2,930

    )

    (3,824

    )

    TOTAL COMPREHENSIVE INCOME / (LOSS) FOR THE PERIOD ATTRIBUTABLE TO OWNERS OF THE PARENT

    17,915

     

    68,104

     

    (4,667

    )

    20,534

     

     

     

     

     

     

    EARNINGS PER SHARE (EPS):

     

     

     

     

    Weighted average number of shares outstanding - Basic

    58,213,743

     

    57,176,428

     

    58,439,085

     

    57,603,730

     

    Weighted average number of shares outstanding - Diluted

    58,657,357

     

    58,070,352

     

    58,799,599

     

    58,210,601

     

    Basic EPS (£)

    0.33

     

    1.24

     

    (0.03

    )

    0.42

     

    Diluted EPS (£)

    0.32

     

    1.22

     

    (0.03

    )

    0.42

     

    CONDENSED CONSOLIDATED BALANCE SHEETS

     

     

    March 31, 2024

    June 30, 2023

    March 31, 2023

     

    £’000

    £’000

    £’000

    ASSETS - NON-CURRENT

     

     

     

    Goodwill

    264,289

     

    240,818

     

    186,946

     

    Intangible assets

    57,179

     

    66,216

     

    50,924

     

    Property, plant and equipment

    22,204

     

    25,940

     

    26,459

     

    Lease right-of-use assets

    52,645

     

    65,084

     

    58,727

     

    Deferred tax assets

    19,924

     

    20,156

     

    13,515

     

    Financial assets and other receivables

    7,380

     

    5,242

     

    1,992

     

    TOTAL

    423,621

     

    423,456

     

    338,563

     

    ASSETS - CURRENT

     

     

     

    Trade and other receivables

    175,671

     

    177,866

     

    183,533

     

    Corporation tax receivable

    2,960

     

    4,042

     

    678

     

    Financial assets

    185

     

    56

     

    136

     

    Cash and cash equivalents

    190,021

     

    164,703

     

    199,200

     

    TOTAL

    368,837

     

    346,667

     

    383,547

     

    TOTAL ASSETS

    792,458

     

    770,123

     

    722,110

     

    LIABILITIES - CURRENT

     

     

     

    Lease liabilities

    14,300

     

    14,573

     

    13,859

     

    Trade and other payables

    82,262

     

    91,159

     

    92,649

     

    Corporation tax payable

    3,062

     

    5,940

     

    5,569

     

    Contingent consideration

    4,619

     

    7,650

     

    3,511

     

    Deferred consideration

    3,205

     

    1,267

     

    6,538

     

    TOTAL

    107,448

     

    120,589

     

    122,126

     

    LIABILITIES - NON CURRENT

     

     

     

    Lease liabilities

    42,961

     

    54,441

     

    50,193

     

    Deferred tax liabilities

    13,297

     

    14,623

     

    10,152

     

    Contingent consideration

     

    3,809

     

     

    Deferred consideration

    3,411

     

    4,837

     

    1,363

     

    Other liabilities

    548

     

    516

     

    525

     

    TOTAL

    60,217

     

    78,226

     

    62,233

     

    EQUITY

     

     

     

    Share capital

    1,169

     

    1,155

     

    1,153

     

    Share premium

    21,208

     

    14,625

     

    13,546

     

    Merger relief reserve

    49,643

     

    42,805

     

    39,976

     

    Retained earnings

    570,878

     

    522,926

     

    491,739

     

    Other reserves

    (18,079

    )

    (10,176

    )

    (8,515

    )

    Investment in own shares

    (26

    )

    (27

    )

    (148

    )

    TOTAL

    624,793

     

    571,308

     

    537,751

     

    TOTAL LIABILITIES AND EQUITY

    792,458

     

    770,123

     

    722,110

     

    CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

     

     

    Nine Months Ended
    March 31

    Three Months Ended
    March 31

     

    2024

    2023

    2024

    2023

     

    £’000

    £’000

    £’000

    £’000

    OPERATING ACTIVITIES

     

     

     

     

    Profit / (Loss) for the period

    18,976

     

    71,105

     

    (1,737

    )

    24,358

     

    Income tax charge

    8,413

     

    18,122

     

    1,208

     

    6,030

     

    Non-cash adjustments

    43,760

     

    40,216

     

    11,927

     

    15,242

     

    Tax paid

    (7,707

    )

    (16,189

    )

    (2,893

    )

    (6,142

    )

    Net changes in working capital

    (8,811

    )

    (22,063

    )

    (5,497

    )

    (14,428

    )

    Net cash from operating activities

    54,631

     

    91,191

     

    3,008

     

    25,060

     

     

     

     

     

     

    INVESTING ACTIVITIES

     

     

     

     

    Purchase of non-current assets (tangibles and intangibles)

    (3,696

    )

    (11,804

    )

    (1,496

    )

    (4,213

    )

    Proceeds from disposal of non-current assets

    36

     

    148

     

    63

     

    132

     

    Payment for acquisition of subsidiary, net of cash acquired

    (19,223

    )

    (35,773

    )

    (12,513

    )

    (3,376

    )

    Other acquisition-related settlements

    (6,680

    )

     

     

     

    Interest received

    5,599

     

    1,851

     

    2,077

     

    1,054

     

    Net cash used in investing activities

    (23,964

    )

    (45,578

    )

    (11,869

    )

    (6,403

    )

     

     

     

     

     

    FINANCING ACTIVITIES

     

     

     

     

    Proceeds from sublease

    129

     

    325

     

    42

     

    88

     

    Repayment of lease liabilities

    (10,793

    )

    (9,960

    )

    (3,373

    )

    (3,469

    )

    Interest and debt financing costs paid

    (1,611

    )

    (3,532

    )

    (1,028

    )

    (3,109

    )

    Grant received

    822

     

    472

     

    592

     

    252

     

    Proceeds from exercise of options

    6,586

     

    4,398

     

    3,457

     

    2,132

     

    Net cash used in financing activities

    (4,867

    )

    (8,297

    )

    (310

    )

    (4,106

    )

    Net change in cash and cash equivalents

    25,800

     

    37,316

     

    (9,171

    )

    14,551

     

     

     

     

     

     

    Cash and cash equivalents at the beginning of the period

    164,703

     

    162,806

     

    198,602

     

    185,323

     

    Exchange differences on cash and cash equivalents

    (482

    )

    (922

    )

    590

     

    (674

    )

    Cash and cash equivalents at the end of the period

    190,021

     

    199,200

     

    190,021

     

    199,200

     

    RECONCILIATION OF IFRS FINANCIAL MEASURES TO NON-IFRS FINANCIAL MEASURES

    RECONCILIATION OF REVENUE (DECREASE)/GROWTH RATE AS REPORTED UNDER IFRS TO REVENUE GROWTH RATE AT CONSTANT CURRENCY:

     

     

    Nine Months Ended
    March 31

    Three Months Ended
    March 31

     

    2024

    2023

    2024

    2023

    REVENUE (DECREASE) / GROWTH RATE AS REPORTED UNDER IFRS

    (9.7

    )%

    27.5

    %

    (14.3

    )%

    20.3

    %

    Foreign exchange rates impact

    2.7

    %

    (6.5

    )%

    2.5

    %

    (5.7

    )%

    REVENUE (DECREASE) / GROWTH RATE AT CONSTANT CURRENCY

    (7.0

    )%

    21.0

    %

    (11.8

    )%

    14.6

    %

    RECONCILIATION OF ADJUSTED PROFIT BEFORE TAX AND ADJUSTED PROFIT FOR THE PERIOD:

     

     

    Nine Months Ended
    March 31

    Three Months Ended
    March 31

     

    2024

    2023

    2024

    2023

     

    £’000

    £’000

    £’000

    £’000

     

     

     

     

     

    PROFIT / (LOSS) BEFORE TAX

    27,389

     

    89,227

     

    (529

    )

    30,388

     

    Adjustments:

     

     

     

     

    Share-based compensation expense

    29,740

     

    24,135

     

    6,184

     

    8,226

     

    Amortisation of acquired intangible assets

    9,930

     

    9,427

     

    2,845

     

    3,220

     

    Foreign currency exchange (gains) / losses, net

    2,864

     

    10,030

     

    179

     

    2,497

     

    Restructuring costs

    7,259

     

    3,683

     

    7,259

     

    2,570

     

    Fair value movement of contingent consideration

    (9,148

    )

    (10,650

    )

    (442

    )

    (3,507

    )

    Total adjustments

    40,645

     

    36,625

     

    16,025

     

    13,006

     

    ADJUSTED PROFIT BEFORE TAX

    68,034

     

    125,852

     

    15,496

     

    43,394

     

     

     

     

     

     

    PROFIT / (LOSS) BEFORE TAX

    18,976

     

    71,105

     

    (1,737

    )

    24,358

     

    Adjustments:

     

     

     

     

    Adjustments to profit before tax

    40,645

     

    36,625

     

    16,025

     

    13,006

     

    Tax impact of adjustments

    (6,503

    )

    (8,299

    )

    (1,587

    )

    (3,247

    )

    ADJUSTED PROFIT FOR THE PERIOD

    53,118

     

    99,431

     

    12,701

     

    34,117

     

     

     

     

     

     

    RECONCILIATION OF ADJUSTED DILUTED EARNINGS PER SHARE:

     

     

    Nine Months Ended
    March 31

    Three Months Ended
    March 31

     

    2024

    2023

    2024

    2023

     

    £’000

    £’000

    £’000

    £’000

     

     

     

     

     

    DILUTED EARNINGS PER SHARE (£)

    0.32

     

    1.22

     

    (0.03

    )

    0.42

     

    Adjustments:

     

     

     

     

    Share-based compensation expense

    0.51

     

    0.42

     

    0.11

     

    0.14

     

    Amortisation of acquired intangible assets

    0.17

     

    0.16

     

    0.05

     

    0.06

     

    Foreign currency exchange (gains) / losses, net

    0.05

     

    0.17

     

     

    0.04

     

    Restructuring costs

    0.12

     

    0.06

     

    0.12

     

    0.04

     

    Fair value movement of contingent consideration

    (0.15

    )

    (0.18

    )

     

    (0.05

    )

    Tax impact of adjustments

    (0.11

    )

    (0.14

    )

    (0.03

    )

    (0.06

    )

    Total adjustments

    0.59

     

    0.49

     

    0.25

     

    0.17

     

    ADJUSTED DILUTED EARNINGS PER SHARE (£)

    0.91

     

    1.71

     

    0.22

     

    0.59

     

    RECONCILIATION OF NET CASH FROM OPERATING ACTIVITIES TO ADJUSTED FREE CASH FLOW

     

     

    Nine Months Ended
    March 31

    Three Months Ended
    March 31

     

    2024

    2023

    2024

    2023

     

    £’000

    £’000

    £’000

    £’000

     

     

     

     

     

    Net cash from operating activities

    54,631

     

    91,191

     

    3,008

     

    25,060

     

    Adjustments:

     

     

     

     

    Grant received

    822

     

    472

     

    592

     

    252

     

    Net purchase of non-current assets (tangible and intangible)

    (3,660

    )

    (11,656

    )

    (1,433

    )

    (4,081

    )

    Adjusted Free cash flow

    51,793

     

    80,007

     

    2,167

     

    21,231

     

    SUPPLEMENTARY INFORMATION

    SHARE-BASED COMPENSATION EXPENSE

     

     

    Nine Months Ended
    March 31

    Three Months Ended
    March 31

     

    2024

    2023

    2024

    2023

     

    £’000

    £’000

    £’000

    £’000

     

     

     

     

     

    Direct cost of sales

    21,432

    15,996

    5,114

    5,699

    Selling, general and administrative expenses

    8,308

    8,139

    1,070

    2,527

    Total

    29,740

    24,135

    6,184

    8,226

    DEPRECIATION AND AMORTISATION

     

     

    Nine Months Ended
    March 31

    Three Months Ended
    March 31

     

    2024

    2023

    2024

    2023

     

    £’000

    £’000

    £’000

    £’000

     

     

     

     

     

    Direct cost of sales

    14,898

    13,242

    4,849

    4,616

    Selling, general and administrative expenses

    12,410

    11,406

    3,698

    3,945

    Total

    27,308

    24,648

    8,547

    8,561

    EMPLOYEES, TOP 10 CUSTOMERS AND REVENUE SPLIT

     

     

    Nine Months Ended
    March 31

    Three Months Ended
    March 31

     

    2024

    2023

    2024

    2023

     

     

     

     

     

    Closing number of total employees (including directors)

    11,025

     

    11,742

     

    11,025

     

    11,742

     

    Average operational employees

    10,446

     

    10,960

     

    10,127

     

    10,818

     

     

     

     

     

     

    Top 10 customers %

    34

    %

    33

    %

    34

    %

    33

    %

    Number of clients with > £1m of revenue

    (rolling 12 months)

    142

     

    155

     

    142

     

    155

     

     

     

     

     

     

    Geographic split of revenue %

     

     

     

     

    North America

    31

    %

    33

    %

    30

    %

    32

    %

    Europe

    26

    %

    23

    %

    28

    %

    24

    %

    UK

    34

    %

    39

    %

    35

    %

    38

    %

    Rest of World (RoW)

    9

    %

    5

    %

    7

    %

    6

    %

    Industry vertical split of revenue %

     

     

     

     

    Payments

    26

    %

    29

    %

    24

    %

    29

    %

    Banking and Capital Markets

    14

    %

    16

    %

    14

    %

    16

    %

    Insurance

    9

    %

    7

    %

    9

    %

    8

    %

    TMT

    23

    %

    22

    %

    24

    %

    21

    %

    Mobility

    10

    %

    10

    %

    10

    %

    11

    %

    Other

    18

    %

    16

    %

    19

    %

    15

    %

    FOOTNOTES

    (1) The presentation of the income statement has been changed to no longer separately disclose the net impairment gains/(losses) on financial assets on the face of the Condensed Consolidated Statements of Comprehensive Income, but include them within Selling, general and administrative expenses.


    The Endava (A) Stock at the time of publication of the news with a raise of +3,70 % to 28,00EUR on Tradegate stock exchange (23. Mai 2024, 09:31 Uhr).


    Business Wire (engl.)
    0 Follower
    Autor folgen

    Weitere Artikel des Autors


    Endava Announces Third Quarter Fiscal Year 2024 Results Endava plc (NYSE: DAVA) ("Endava" or the "Company"), a leading technology services company combining world-class engineering, industry expertise and a people-centric mindset, today announced results for the three months ended March 31, 2024, the …